OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,912,294 | +17.1% | 5,445,910 | 0.0% | 0.78% | +2.6% |
| Q2 2023 | $17,862,585 | -1.1% | 5,445,910 | -22.2% | 0.76% | +63.2% |
| Q1 2023 | $18,062,900 | +42.2% | 7,001,124 | +2.5% | 0.47% | -15.5% |
| Q4 2022 | $12,700,201 | +52.8% | 6,828,065 | +51.2% | 0.55% | +32.2% |
| Q3 2022 | $8,310,000 | +34.1% | 4,516,300 | +56.7% | 0.42% | +28.5% |
| Q2 2022 | $6,198,000 | – | 2,882,706 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |